Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17531105rdf:typepubmed:Citationlld:pubmed
pubmed-article:17531105lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:17531105lifeskim:mentionsumls-concept:C0023413lld:lifeskim
pubmed-article:17531105lifeskim:mentionsumls-concept:C1522484lld:lifeskim
pubmed-article:17531105lifeskim:mentionsumls-concept:C1527249lld:lifeskim
pubmed-article:17531105lifeskim:mentionsumls-concept:C0123931lld:lifeskim
pubmed-article:17531105lifeskim:mentionsumls-concept:C0036525lld:lifeskim
pubmed-article:17531105lifeskim:mentionsumls-concept:C0879427lld:lifeskim
pubmed-article:17531105lifeskim:mentionsumls-concept:C1708063lld:lifeskim
pubmed-article:17531105pubmed:issue6lld:pubmed
pubmed-article:17531105pubmed:dateCreated2007-5-28lld:pubmed
pubmed-article:17531105pubmed:abstractTextPanitumumab is a fully human monoclonal antibody directed against the epidermal growth factor receptor and is indicated for patients with metastatic colorectal cancer (mCRC) who have experienced disease progression after standard chemotherapy. We conducted this phase II study to assess the ability of panitumumab to be administered with first-line irinotecan-containing regimens in patients with mCRC.lld:pubmed
pubmed-article:17531105pubmed:languageenglld:pubmed
pubmed-article:17531105pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17531105pubmed:citationSubsetIMlld:pubmed
pubmed-article:17531105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17531105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17531105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17531105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17531105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17531105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17531105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17531105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17531105pubmed:statusMEDLINElld:pubmed
pubmed-article:17531105pubmed:monthMarlld:pubmed
pubmed-article:17531105pubmed:issn1533-0028lld:pubmed
pubmed-article:17531105pubmed:authorpubmed-author:BerlinJordanJlld:pubmed
pubmed-article:17531105pubmed:authorpubmed-author:BEAUCHAMPW...lld:pubmed
pubmed-article:17531105pubmed:authorpubmed-author:ChanDavidDlld:pubmed
pubmed-article:17531105pubmed:authorpubmed-author:TchekmedyianS...lld:pubmed
pubmed-article:17531105pubmed:authorpubmed-author:AmadoRafael...lld:pubmed
pubmed-article:17531105pubmed:authorpubmed-author:PoseyJamesJlld:pubmed
pubmed-article:17531105pubmed:authorpubmed-author:HuEddieElld:pubmed
pubmed-article:17531105pubmed:authorpubmed-author:MalikImtiazIlld:pubmed
pubmed-article:17531105pubmed:authorpubmed-author:YangLiqiangLlld:pubmed
pubmed-article:17531105pubmed:issnTypePrintlld:pubmed
pubmed-article:17531105pubmed:volume6lld:pubmed
pubmed-article:17531105pubmed:ownerNLMlld:pubmed
pubmed-article:17531105pubmed:authorsCompleteYlld:pubmed
pubmed-article:17531105pubmed:pagination427-32lld:pubmed
pubmed-article:17531105pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:17531105pubmed:meshHeadingpubmed-meshheading:17531105...lld:pubmed
pubmed-article:17531105pubmed:meshHeadingpubmed-meshheading:17531105...lld:pubmed
pubmed-article:17531105pubmed:meshHeadingpubmed-meshheading:17531105...lld:pubmed
pubmed-article:17531105pubmed:meshHeadingpubmed-meshheading:17531105...lld:pubmed
pubmed-article:17531105pubmed:meshHeadingpubmed-meshheading:17531105...lld:pubmed
pubmed-article:17531105pubmed:meshHeadingpubmed-meshheading:17531105...lld:pubmed
pubmed-article:17531105pubmed:meshHeadingpubmed-meshheading:17531105...lld:pubmed
pubmed-article:17531105pubmed:meshHeadingpubmed-meshheading:17531105...lld:pubmed
pubmed-article:17531105pubmed:meshHeadingpubmed-meshheading:17531105...lld:pubmed
pubmed-article:17531105pubmed:meshHeadingpubmed-meshheading:17531105...lld:pubmed
pubmed-article:17531105pubmed:meshHeadingpubmed-meshheading:17531105...lld:pubmed
pubmed-article:17531105pubmed:meshHeadingpubmed-meshheading:17531105...lld:pubmed
pubmed-article:17531105pubmed:meshHeadingpubmed-meshheading:17531105...lld:pubmed
pubmed-article:17531105pubmed:meshHeadingpubmed-meshheading:17531105...lld:pubmed
pubmed-article:17531105pubmed:meshHeadingpubmed-meshheading:17531105...lld:pubmed
pubmed-article:17531105pubmed:meshHeadingpubmed-meshheading:17531105...lld:pubmed
pubmed-article:17531105pubmed:year2007lld:pubmed
pubmed-article:17531105pubmed:articleTitlePanitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer.lld:pubmed
pubmed-article:17531105pubmed:affiliationVanderbilt University Medical Center, Nashville, TN 37232-6307, USA. jordan.berlin@vanderbilt.edulld:pubmed
pubmed-article:17531105pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17531105pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17531105pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:17531105pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17531105lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17531105lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17531105lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17531105lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17531105lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17531105lld:pubmed